Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ERN1 | O75460 | 6/20 | 0.47 |
| ▸ | TLR2 | O60603 | 1/20 | 0.45 |
| ▸ | TLR1 | Q15399 | 1/20 | 0.45 |
| ▸ | TLR6 | Q9Y2C9 | 1/20 | 0.45 |
| ▸ | TRIM24 | O15164 | 1/20 | 0.41 |
| ▸ | TRIM33 | Q9UPN9 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 2/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | THRB | P10828 | 1/20 | 0.39 |
| ▸ | BLM | P54132 | 1/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.39 |
| ▸ | CA1 | P00915 | 1/20 | 0.38 |
| ▸ | CA2 | P00918 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.37 |
| ▸ | TSHR | P16473 | 1/20 | 0.37 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
| ▸ | ESR1 | P03372 | 1/20 | 0.35 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.35 |
| ▸ | IAPP | P10997 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10909747 | 0.84 | LMNA (0.46) | ERN1TRIM24TRIM33LMNAKMT2A | |
| SCHEMBL31312357 | 0.80 | LMNA (0.46) | ERN1TRIM24TRIM33LMNAKMT2A | |
| SCHEMBL3966498 | 0.80 | ERN1 (0.55) | ERN1TLR2TLR1TLR6TRIM24 | |
| SCHEMBL26116456 | 0.80 | ERN1 (0.43) | ERN1TLR2TLR1TLR6TRIM24 | |
| SCHEMBL30679775 | 0.80 | ERN1 (0.43) | ERN1TLR2TLR1TLR6TRIM24 | |
| SCHEMBL14337150 | 0.78 | SIRT2 (0.47) | KMT2AMEN1CA1CA2ALDH1A1 | |
| SCHEMBL4310583 | 0.76 | ESR1 (0.46) | LMNAKMT2AMEN1TDP1CA1 | |
| SCHEMBL14515524 | 0.75 | ALDH1A1 (0.48) | KMT2AMEN1THRBTDP1ALDH1A1 | |
| SCHEMBL2007240 | 0.75 | ERN1 (0.50) | ERN1TLR2TLR1TLR6TRIM24 | |
| SCHEMBL15525107 | 0.73 | LMNA (0.46) | ERN1TRIM24TRIM33LMNAKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7220870-B2 | Hydrolytic kinetic resolution of cyclic substrates | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2007-05-22 | — | — | US | disclosed |
| EP-0817765-B1 | STEREOSELECTIVE RING OPENING REACTIONS | HARVARD COLLEGE (US) | 2006-02-01 | — | — | EP | disclosed |
| US-20050209471-A1 | Stereoselective addition of a nucleophile to a reactive pi -bond of a substrate using a chiral, non-racemic catalysts, producing a stereoisomerically enriched product | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2005-09-22 | — | — | US | disclosed |
| US-20050187392-A1 | Hydrolytic kinetic resolution of cyclic substrates | HARVARD UNIVERSITY (US) | 2005-08-25 | — | — | US | disclosed |
| US-6844448-B2 | Main-group metal-based asymmetric catalysts and applications thereof | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2005-01-18 | — | — | US | disclosed |
| US-6841667-B2 | Nucleophilic kinetic resolution of cyclic substrates using silyl azides | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2005-01-11 | — | — | US | disclosed |
| US-6800766-B2 | CATALYZING THE DECYCLIZATION OF RACEMIC AND DIASTEREOMERIC EPOXIDES MIXTURES IN THE PRESENCE OF A NON-RACEMIC, CHIRAL CATALYST; PHARMACEUTICAL SYNTHESIS | PRESIDENT AND FELLOWS OF HARVARD COLLEGE | 2004-10-05 | — | — | US | disclosed |
| US-20040044233-A1 | Nucleophilic kinetic resolution of cyclic substrates using silyl azides | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2004-03-04 | — | — | US | disclosed |
| US-20030187249-A1 | Main-group metal-based asymmetric catalysts and applications thereof | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2003-10-02 | — | — | US | disclosed |
| US-20030139614-A1 | Hydrolytic kinetic resolution of cyclic substrates | PRESIDENT AND FELLOWS OF HARVARD COLLEGE | 2003-07-24 | — | — | US | disclosed |
| EP-1073613-A2 | MAIN-GROUP METAL-BASED ASYMMETRIC CATALYSTS AND APPLICATIONS THEREOF | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2001-02-07 | — | — | EP | disclosed |
| US-6130340-A | CATALYST SELECTIVITY; DRUG CHEMICAL INTERMEDIATES | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2000-10-10 | — | — | US | disclosed |
| WO-2000050365-A1 | ASYMMETRIC CYCLOADDITION REACTIONS | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2000-08-31 | — | — | WO | disclosed |
| WO-2000009463-A1 | STEREOSELECTIVE RING OPENING REACTIONS | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2000-02-24 | — | — | WO | disclosed |
| WO-1999056699-A2 | MAIN-GROUP METAL-BASED ASYMMETRIC CATALYSTS AND APPLICATIONS THEREOF | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 1999-11-11 | — | — | WO | disclosed |
| US-5929232-A | REACTING NUCLEOPHILE AND RACEMIC MIXTURE OF CHIRAL CYCLIC SUBSTRATE IN PRESENCE OF NON-RACEMIC CHIRAL CATALYST TO PRODUCE STEREOISOMERICALLY ENRICHED CYCLIC SUBSTRATE BY KINETIC RESOLUTION | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 1999-07-27 | — | — | US | disclosed |
| WO-1999036375-A1 | ASYMMETRIC CYCLOADDITION REACTIONS | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 1999-07-22 | — | — | WO | disclosed |
| EP-0817765-A1 | STEREOSELECTIVE RING OPENING REACTIONS | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 1998-01-14 | — | — | EP | disclosed |
| US-5665890-A | CHEMICAL SYNTHESIS COMPRISING REACTING A NUCLEOPHILE AND A CHIRAL OR PROCHIRAL CYCLIC SUBSTRATE | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 1997-09-09 | — | — | US | disclosed |
| WO-1996028402-A1 | STEREOSELECTIVE RING OPENING REACTIONS | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 1996-09-19 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030139614-A1 | Hydrolytic kinetic resolution of cyclic substrates | EPHX2, EPHX1, APEH | ERN1 1547/4885TLR2 4849/4885TLR1 4828/4885 |
| US-20050209471-A1 | Stereoselective addition of a nucleophile to a reactive pi -bond of a substrate using a chiral, non-racemic catalysts, producing a stereoisomerically enriched product | DNTT, PCNA, SAMHD1 | ERN1 1320/4885TLR2 4507/4885TLR1 4185/4885 |
| US-20050187392-A1 | Hydrolytic kinetic resolution of cyclic substrates | EPHX2, EPHX1, APEH | ERN1 1547/4885TLR2 4849/4885TLR1 4828/4885 |
| US-20040044233-A1 | Nucleophilic kinetic resolution of cyclic substrates using silyl azides | SAMHD1, PCNA, ESD | ERN1 666/4885TLR2 4831/4885TLR1 4760/4885 |
| US-20030187249-A1 | Main-group metal-based asymmetric catalysts and applications thereof | DCX, DNTT, CA3 | ERN1 2147/4885TLR2 3724/4885TLR1 3385/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.